Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Hematopoiesis-stimulating compounds from SmithKine Beecham and Nycomed

July 11, 1997

No Comments

Natural products for hyperlipidemia

July 11, 1997

No Comments

Immunological effects of HMG-CoA reductase inhibitors in humans

July 11, 1997

No Comments

Interleukin-11 reviewed

July 11, 1997

No Comments

FDA clears Bayer's cholesterol-lowering agent

July 10, 1997

No Comments

Exocell presents humanized MAb for diabetic nephropathy

July 10, 1997

No Comments

Novel hemoregulatory compounds from SKB

July 10, 1997

No Comments

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

July 9, 1997

No Comments

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

No Comments

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

July 9, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Hematopoiesis-stimulating compounds from SmithKine Beecham and Nycomed

Natural products for hyperlipidemia

Immunological effects of HMG-CoA reductase inhibitors in humans

Interleukin-11 reviewed

FDA clears Bayer's cholesterol-lowering agent

Exocell presents humanized MAb for diabetic nephropathy

Novel hemoregulatory compounds from SKB

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

MGI Pharma launches INFeD for anemia in cancer patients

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Endocrine/metabolic RSS

Endocrine/metabolic
RSS